FDA Drug Recalls

Recalls / Class II

Class IID-0957-2023

Product

EPINEPHrine, 2 mg added to dextrose 5% 250mL, Concentration = 8 mcg/mL, IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6030-1.

Affected lot / code info
Lot: 36-251702, Exp. 8/29/2023

Why it was recalled

Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Recalling firm

Firm
Central Admixture Pharmacy Services, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2200 S 43rd Ave, N/A, Phoenix, Arizona 85043-3909

Distribution

Quantity
333 Bags
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2023-07-14
FDA classified
2023-08-01
Posted by FDA
2023-08-09
Terminated
2025-03-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0957-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls